Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 785.98 Cr |
| Price/Earnings (Trailing) | 8.81 |
| Price/Sales (Trailing) | 1.11 |
| EV/EBITDA | 3.01 |
| Price/Free Cashflow | 15.25 |
| MarketCap/EBT | 6.52 |
| Enterprise Value | 390.29 Cr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 2.2% |
| Price Change 1M | -9.8% |
| Price Change 6M | -22.6% |
| Price Change 1Y | -33% |
| 3Y Cumulative Return | -1.1% |
| 5Y Cumulative Return | 14.3% |
| 7Y Cumulative Return | 18.2% |
| 10Y Cumulative Return | 23.1% |
| Revenue (TTM) |
| 706.98 Cr |
| Rev. Growth (Yr) | 5.6% |
| Earnings (TTM) | 89.26 Cr |
| Earnings Growth (Yr) | -7.9% |
Profitability | |
|---|---|
| Operating Margin | 18% |
| EBT Margin | 17% |
| Return on Equity | 8.76% |
| Return on Assets | 7.66% |
| Free Cashflow Yield | 6.56% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -8.23 Cr |
| Cash Flow from Operations (TTM) | 65.2 Cr |
| Cash Flow from Financing (TTM) | -17.3 Cr |
| Cash & Equivalents | 408.76 Cr |
| Free Cash Flow (TTM) | 62.76 Cr |
| Free Cash Flow/Share (TTM) | 36.56 |
Balance Sheet | |
|---|---|
| Total Assets | 1.17 kCr |
| Total Liabilities | 146.59 Cr |
| Shareholder Equity | 1.02 kCr |
| Current Assets | 635.98 Cr |
| Current Liabilities | 60.59 Cr |
| Net PPE | 125.48 Cr |
| Inventory | 36.25 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.01 |
| Debt/Equity | 0.01 |
| Interest Coverage | 62.46 |
| Interest/Cashflow Ops | 37.37 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 3 |
| Dividend Yield | 0.66% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Profitability: Recent profitability of 13% is a good sign.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -5.6% in past one year. In past three years, revenues have changed by -56.7%.
Size: It is a small market cap company and can be volatile.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.1% return compared to 12.8% by NIFTY 50.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Profitability: Recent profitability of 13% is a good sign.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Growth: Declining Revenues! Trailing 12m revenue has fallen by -5.6% in past one year. In past three years, revenues have changed by -56.7%.
Size: It is a small market cap company and can be volatile.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.1% return compared to 12.8% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 0.66% |
| Dividend/Share (TTM) | 3 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 52 |
Financial Health | |
|---|---|
| Current Ratio | 10.5 |
| Debt/Equity | 0.01 |
Technical Indicators | |
|---|---|
| RSI (14d) | 33.88 |
| RSI (5d) | 62.85 |
| RSI (21d) | 26.74 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Buy |
| SMA 5 Signal | Buy |
| SMA 10 Signal |
Summary of Sree Rayalaseema Hi-Strength Hypo's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Understand Sree Rayalaseema Hi-Strength Hypo ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Gowri Gopal Hospitals Private Limited | 21.8% |
| TGV Projects and Investments Prtivate Ltd | 15.26% |
| Sree Rayalaseema Galaxy Projects Private Ltd | 8.82% |
| Investor Education and Protection Fund | 6.75% |
| T G Bharath | 2.92% |
| Sree Rayalaseema Dutch Kassenbouw Private Ltd | 2.91% |
Detailed comparison of Sree Rayalaseema Hi-Strength Hypo against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Comprehensive comparison against sector averages
SRHHYPOLTD metrics compared to Chemicals
| Category | SRHHYPOLTD | Chemicals |
|---|---|---|
| PE | 8.85 | 22.42 |
| PS | 1.12 | 1.04 |
| Growth | -5.6 % | 3.4 % |
Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal. The company provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; chloramine, purichlor, oleum, sodium dichloroisocyanurate, and hydrogen gas; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder and solution, and water treatment chemicals. It is involved in the generation and distribution of power through thermal, wind, and solar plants; and coal trading business. The company also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
SRHHYPOLTD vs Chemicals (2021 - 2026)
| TGV Securities Prtivate Limited | 2.43% |
| T G Rajyalakshmi | 2.42% |
| T G Shilpa Bharath | 2.31% |
| TGV SRAAC Limited | 1.43% |
| TGV Industries Private Limited | 0.05% |
| Brilliant Industries Private Limited | 0.05% |
| Jyotsna S Mysore | 0.04% |
| Boda Mourya | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
| 158 |
| 155 |
| 121 |
| 144 |
| 145 |
| 143 |
| Profit Before exceptional items and Tax | -11.4% | 32 | 36 | 30 | 36 | 26 | 31 |
| Exceptional items before tax | 82.6% | 0 | -4.76 | 0 | 0 | 0 | -4.99 |
| Total profit before tax | 3.3% | 32 | 31 | 30 | 36 | 26 | 26 |
| Current tax | -4.6% | 8.11 | 8.45 | 8.48 | 9.13 | 6.9 | 5.91 |
| Deferred tax | -7.5% | 0.43 | 0.47 | 0.12 | 1.41 | 0.34 | 0.27 |
| Total tax | -4.8% | 8.53 | 8.91 | 8.6 | 11 | 7.23 | 6.18 |
| Total profit (loss) for period | 4.8% | 23 | 22 | 22 | 25 | 19 | 20 |
| Other comp. income net of taxes | 270.4% | 31 | 9.1 | 21 | 14 | 14 | -37.45 |
| Total Comprehensive Income | 71% | 54 | 32 | 42 | 39 | 32 | -17.9 |
| Earnings Per Share, Basic | 4.2% | 13.57 | 13.06 | 12.56 | 14.74 | 10.85 | 11.39 |
| Earnings Per Share, Diluted | 4.2% | 13.57 | 13.06 | 12.56 | 14.74 | 10.85 | 11.39 |
| -2.9% |
| 34 |
| 35 |
| 39 |
| 29 |
| 24 |
| 23 |
| Finance costs | -67.1% | 1.98 | 3.98 | 2.03 | 3.21 | 5.48 | 8.69 |
| Depreciation and Amortization | -53% | 5.7 | 11 | 19 | 19 | 51 | 50 |
| Other expenses | -1.3% | 153 | 155 | 229 | 163 | 125 | 130 |
| Total Expenses | -28.6% | 550 | 770 | 1,494 | 1,141 | 837 | 648 |
| Profit Before exceptional items and Tax | 5.9% | 127 | 120 | 190 | 137 | 81 | 45 |
| Exceptional items before tax | 65.8% | -3.06 | -10.86 | 0 | 0 | 0 | 0 |
| Total profit before tax | 13.9% | 124 | 109 | 190 | 137 | 81 | 45 |
| Current tax | 3.7% | 29 | 28 | 36 | 35 | 30 | 20 |
| Deferred tax | 388.1% | 2.7 | 0.41 | -0.09 | -0.87 | -10.23 | -12.58 |
| Total tax | 14.8% | 32 | 28 | 36 | 34 | 20 | 7.54 |
| Total profit (loss) for period | 16.5% | 93 | 80 | 154 | 103 | 61 | 38 |
| Other comp. income net of taxes | 232.8% | 33 | -23.1 | 32 | 85 | 20 | -46.49 |
| Total Comprehensive Income | 123.2% | 126 | 57 | 187 | 187 | 81 | -8.58 |
| Earnings Per Share, Basic | 16.8% | 53.99 | 46.36 | 89.9 | 59.88 | 35.3 | 22.09 |
| Earnings Per Share, Diluted | 16.8% | 53.99 | 46.36 | 89.9 | 59.88 | 35.3 | 22.09 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| Investment property | -2.1% | 7.51 | 7.65 | 8.1 | 8.28 | 2.6 | 2.6 |
| Non-current investments | 11.2% | 407 | 366 | 345 | 253 | 246 | 214 |
| Total non-current financial assets | 10.5% | 410 | 371 | 349 | 256 | 252 | 217 |
| Total non-current assets | 8.1% | 522 | 483 | 458 | 361 | 361 | 330 |
| Total assets | 9.2% | 1,156 | 1,059 | 1,008 | 902 | 893 | 919 |
| Borrowings, non-current | -1.2% | 9.89 | 10 | 0 | 0 | 0 | 0.28 |
| Total non-current financial liabilities | 11.1% | 11 | 10 | 0 | 4.92 | 6.13 | 7.53 |
| Provisions, non-current | -10.8% | 3.06 | 3.31 | 0 | 2.71 | 1.97 | 2.26 |
| Total non-current liabilities | 19.7% | 86 | 72 | 68 | 51 | 8.9 | 11 |
| Borrowings, current | -37.8% | 2.79 | 3.88 | 0 | 0 | 2.02 | 8.42 |
| Total current financial liabilities | 0% | 23 | 23 | 26 | 28 | 44 | 93 |
| Provisions, current | -24.2% | 2.79 | 3.36 | 4.08 | 3.35 | 3.01 | 1.4 |
| Current tax liabilities | - | 0.86 | 0 | 3.8 | 0.61 | 6.25 | 0 |
| Total current liabilities | -6.3% | 60 | 64 | 64 | 49 | 62 | 157 |
| Total liabilities | 7.4% | 146 | 136 | 132 | 100 | 71 | 168 |
| Equity share capital | 0% | 17 | 17 | 17 | 17 | 17 | 17 |
| Total equity | 9.6% | 1,010 | 922 | 876 | 802 | 822 | 751 |
| Total equity and liabilities | 9.2% | 1,156 | 1,059 | 1,008 | 902 | 893 | 919 |
| 31 |
| -7.8 |
| 79 |
| 32 |
| - |
| - |
| Net Cashflows From Operating Activities | -33.3% | 89 | 133 | 131 | 60 | - | - |
| Proceeds from sales of PPE | -32.4% | 0.02 | 0.26 | 0 | 0 | - | - |
| Purchase of property, plant and equipment | -73% | 3.24 | 9.29 | -5.25 | 14 | - | - |
| Proceeds from sales of investment property | - | 0 | 0 | -9.87 | 0 | - | - |
| Purchase of investment property | 481.8% | 65 | 12 | 0 | 24 | - | - |
| Interest received | 73.3% | 27 | 16 | 9.07 | 4.41 | - | - |
| Other inflows (outflows) of cash | 99.3% | 0.16 | -116.85 | -103.08 | 0 | - | - |
| Net Cashflows From Investing Activities | 66.4% | -40.44 | -122.43 | -98.62 | -1.2 | - | - |
| Proceeds from borrowings | - | 0 | 0 | 0 | -0.04 | - | - |
| Repayments of borrowings | -113% | 0 | 8.7 | 9.93 | 42 | - | - |
| Dividends paid | -29.3% | 5.15 | 6.87 | 6.01 | 0 | - | - |
| Interest paid | -108.4% | 0.75 | 3.98 | 2.03 | 2.4 | - | - |
| Other inflows (outflows) of cash | -39% | -3.67 | -2.36 | -1.99 | -1.71 | - | - |
| Net Cashflows from Financing Activities | 53.8% | -9.57 | -21.9 | -19.96 | -46.47 | - | - |
| Net change in cash and cash eq. | 399.2% | 39 | -11.7 | 12 | 12 | - | - |
Analysis of Sree Rayalaseema Hi-Strength Hypo's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Mar 31, 2025
| Description | Share | Value |
|---|---|---|
| Chemicals | 91.2% | 159.9 Cr |
| Unallocated | 8.8% | 15.3 Cr |
| Total | 175.2 Cr |